Robert M. Infarinato - Aug 13, 2024 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
VP, Chief Financial Officer
Signature
/s/ Robert M. Infarinato
Stock symbol
PHIO
Transactions as of
Aug 13, 2024
Transactions value $
$0
Form type
4
Date filed
8/15/2024, 04:14 PM
Previous filing
Aug 9, 2024
Next filing
Sep 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Award $0 +8K $0.00 8K Aug 13, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments commencing on the first anniversary of the grant date.
F2 Includes shares of common stock underlying unvested restricted stock units.